Seoul, South Korea

Ji-Yong Jung

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji-Yong Jung: Innovator in Inflammatory Disease Treatment

Introduction

Ji-Yong Jung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of inflammatory diseases. His innovative work focuses on enhancing skin health and combating the effects of aging.

Latest Patents

Ji-Yong Jung holds a patent for a composition aimed at improving inflammatory diseases using ABH antigens. This invention relates to a composition that can enhance the barrier function of epithelial tissue, such as skin, while also improving inflammatory reactions. The composition is designed to promote aging resistance, skin elasticity, and overall skin health. By modulating the expression and activity of ABH antigens, this invention serves as a potential therapeutic agent for treating diseases caused by inflammatory reactions in body tissues, particularly the skin.

Career Highlights

Ji-Yong Jung is associated with the Snur & Db Foundation, where he continues to develop innovative solutions for health-related challenges. His work has garnered attention for its potential applications in external preparations and cosmetics aimed at restoring normal skin function, moisturizing, enhancing wrinkles, and improving skin elasticity.

Collaborations

Ji-Yong Jung collaborates with notable colleagues, including Jang Hee Oh and Dong Hun Lee, who contribute to his research and development efforts.

Conclusion

Ji-Yong Jung's contributions to the field of inflammatory disease treatment highlight his innovative spirit and dedication to improving skin health. His patent on ABH antigens represents a significant advancement in therapeutic options for inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…